2005;365:1046 53. S5.4.4-8. Marshall NS, Wong KKH, Liu PY, et al. Sleep apnea as an indepen- dent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008;31:1079 85. S5.4.4-9. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disor- dered breathing, sleep apnea, and hypertension in a large com- munity-based study. Sleep Heart Health Study. JAMA. 2000;283: 1829 36. S5.4.4-10. Peppard PE, Young T, Palta M, et al. Prospective study of the asso- ciation between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378 84. S5.4.4-11. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307:2169 76. Whelton et al 2017 High Blood Pressure Clinical Practice Guideline e87 S5.4.4-12. Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associ- ated with resistant hypertension. Hypertension. 2011;58:811 7. S5.4.4-13. Muxfeldt ES, Margallo VS, Guimaraes GM, et al. Prevalence and associated factors of obstructive sleep apnea in patients with resis- tant hypertension. Am J Hypertens. 2014;27:1069 78. S5.4.4-14. McEvoy RD, Antic NA, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375:919 31. 6. Nonpharmacological Interventions S6-1. Whelton PK, He J, Appel LJ, et al. Primary prevention of hyper- tension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA. 2002;288: 1882 8. S6-2. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med. 1993;153:186 208. S6-3. Whelton PK. Hypertension curriculum review: epidemiology and the prevention of hypertension. J Clin Hypertens (Greenwich). 2004;6:636 42. S6-4. Whelton PK, Appel LJ, Espeland MA, et al. 